Optimal antithrombotic strategy in patients with atrial fibrillation after coronary stent implantation

Sung Won Jang, Tai Ho Rho, Dong Bin Kim, Eun Joo Cho, Beom June Kwon, Hun Jun Park, Woo Seung Shin, Ji Hoon Kim, Jong Min Lee, Keon Woong Moon, Yong Seog Oh, Ki Dong Yoo, Ho Joong Youn, Man Young Lee, Wook Sung Chung, Ki Bae Seung, Jae Hyung Kim

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Background and Objectives: Little evidence is available on the optimal antithrombotic therapy following percutaneous coronary intervention (PCI) in patients with atrial fibrillation (AF). We investigated the outcomes of antithrombotic treatment strategies in AF patients who underwent PCI. Subjects and Methods: Three hundred sixty-two patients (68.0% men, mean age: 68.3±7.8 years) with AF and who had undergone PCI with stent implantation between 2005 and 2007 were enrolled. The clinical, demographic and procedural characteristics were reviewed and the stroke risk factors as well as antithrombotic regimens were analyzed. Results: The accompanying comorbidities were as follows: hypertension (59.4%), diabetes (37.3%) and congestive heart failure (16.6%). The average number of stroke risk factors was 1.6. At the time of discharge after PCI, warfarin was prescribed for 84 patients (23.2%). Cilostazol was used in addition to dual antiplatelet therapy in 35% of the patients who did not receive warfarin. The mean follow-up period was 615±385 days. The incidences of major adverse cardiac events (MACE), stroke and major bleeding were 11.3%, 3.6% and 4.1%, respectively. By Kaplan-Meier survival analysis, warfarin treatment was not associated with a lower risk of MACE (p=0.886), but it was associated with an increased risk of major bleeding (p=0.002). Conclusion: Oral anticoagulation therapy after PCI may increase hemorrhagic events in Korean AF patients.

Original languageEnglish
Pages (from-to)578-582
Number of pages5
JournalKorean Circulation Journal
Volume41
Issue number10
DOIs
StatePublished - Oct 2011

Keywords

  • Angioplasty
  • Anticoagulants
  • Atrial fibrillation
  • Platelet aggregation inhibitors
  • Stents

Fingerprint

Dive into the research topics of 'Optimal antithrombotic strategy in patients with atrial fibrillation after coronary stent implantation'. Together they form a unique fingerprint.

Cite this